IgE-mediated CMPA typically results in rapid-onset symptoms, such as urticaria, angioedema, vomiting, or anaphylaxis, whereas non-IgE-mediated CMPA is characterized by delayed onset of gastrointestinal and/or cutaneous symptoms [4,5]. This evidence concerns the gene IGHE and angioedema.